IOM suggests ways to share clinical trial data.
نویسنده
چکیده
منابع مشابه
Sharing your thoughts about sharing clinical trial data.
The Institute of Medicine (IOM) is looking for your opinion on sharing clinical trial data. The IOM has convened an ad hoc committee to conduct a consensus study to develop recommendations for sharing clinical trial data. This committee, chaired by Bernard Lo, executive director of the Greenwall Foundation, came together in October 2013 and will deliver a final report by December 2014. As an ea...
متن کاملOverhaul of NCI Clinical Trial System Still in Progress.
A decades-long initiative to improve the National Cancer Institute's Cooperative Group Program has recently made substantial progress. Many credit the April 2010 report from the Institute of Medicine's (IOM) Consensus Committee as instrumental in focusing NCI on reforms essential to create a clinical trial system to meet the challenges of the 21st century. The report recommended that NCI improv...
متن کاملImproving the quality of thyroid cancer care: how does the Thyroid Cancer Care Collaborative cross the Institute of Medicine's Quality Chasm?
BACKGROUND The current systems of healthcare delivery in the United States suffer from problems that often leave patients with inadequate quality of care. In their report entitled "Crossing the Quality Chasm," the Institute of Medicine (IOM) identified reasons for poor and/or inconsistent quality of healthcare delivery and provided recommendations to improve it. The purpose of this review is to...
متن کاملA Global, Neutral Platform for Sharing Trial Data.
icine (IOM) report argues that availability of deidentified (anonymized) patient-level data from clinical trials can permit verification of original results, enhancing public trust and accountability; facilitate other critical research (e.g., evaluation of adverse event rates according to compound class or subpopulation or identification of surrogate end points); and avert duplicate trials, shi...
متن کاملSharing Individual Participant Data (IPD) within the Context of the Trial Reporting System (TRS)
The Institute of Medicine (IOM) [1], journal editors [2,3], and many others [4–6] have called for more widespread, third-party access to the individual participant data (IPD) and associated documentation from clinical trials (i.e., “IPD sharing”). Advocates assert that access to trial IPD will help to address well-established flaws in the current system of communicating trial results, including...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
دوره 187 3 شماره
صفحات -
تاریخ انتشار 2015